Treg therapy

HOUSTON, TEXAS, May 04, 2026 Cellenkos has announced that the U.S. Food and Drug Administration (FDA) has granted Investigational...

SOUTH SAN FRANCISCO, April 29, 2026 TRexBio, Inc. has announced that the first patient has been dosed in the...

HOUSTON, TEXAS, April 27, 2026 Cellenkos Inc. has received U.S. Food and Drug Administration (FDA) clearance to initiate a...